Skip to main content
Top
Published in: Endocrine 2/2016

Open Access 01-08-2016 | Original Article

Electrocardiographic and scintigraphic evaluation of patients with subclinical hyperthyroidism during workout

Authors: Grzegorz Kaminski, Mirosław Dziuk, Ewelina Szczepanek-Parulska, Ariadna Zybek-Kocik, Marek Ruchala

Published in: Endocrine | Issue 2/2016

Login to get access

Abstract

Subclinical hyperthyroidism (sHT) was found to be associated with elevated heart rate, blood pressure and increased risk of extrasystoles. However, the full clinical relevance of morphological and functional implications of sHT on the cardiovascular system is still a matter of debate. The aim of the study was to prospectively assess the influence of endogenous sHT on exercise capacity and cardiac function during workout with the use of exercise electrocardiography (ExECG) and perfusion scintigraphy. The studied group consisted of 44 consecutively recruited patients diagnosed with sHT. In all patients, ExECG, followed by post-exercise myocardial perfusion imaging, was performed. Both ExECG and scintigraphy were performed twice—in the state of sHT and after euthyroidism was restored. An average time period of exercise test was significantly longer in the state of euthyroidism than in sHT. An average oxygen consumption during exercise test was also higher after euthyroidism was achieved when compared to sHT. The end-diastolic and end-systolic volume indexes, stroke volume index and cardiac index were significantly larger in patients with sHT if compared values achieved after euthyroidism restoration. Stroke volume index was negatively correlated with TSH, and positively with free thyroid hormones values in the state of sHT, before euthyroidism was achieved. Cardiac index was positively correlated with free thyroid hormones levels. The obtained results indicate worse physical capacity in subjects with sHT and improvement of several parameters assessed during ExECG and perfusion scintiscan after therapy. Observed changes might reflect the mechanism of the deleterious effect exerted by sHT on the heart.
Literature
1.
go back to reference R.S. Bahn, H.B. Burch, D.S. Cooper, J.R. Garber, M.C. Greenlee, I. Klein, P. Laurberg, I.R. McDougall, V.M. Montori, S.A. Rivkees, D.S. Ross, J.A. Sosa, M.N. Stan, Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr. Pract. 17, 456–520 (2011)CrossRefPubMed R.S. Bahn, H.B. Burch, D.S. Cooper, J.R. Garber, M.C. Greenlee, I. Klein, P. Laurberg, I.R. McDougall, V.M. Montori, S.A. Rivkees, D.S. Ross, J.A. Sosa, M.N. Stan, Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr. Pract. 17, 456–520 (2011)CrossRefPubMed
2.
go back to reference J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002)CrossRefPubMed J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002)CrossRefPubMed
3.
go back to reference B. Biondi, E.A. Palmieri, S. Fazio, C. Cosco, M. Nocera, L. Sacca, S. Filetti, G. Lombardi, F. Perticone, Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J. Clin. Endocrinol. Metab. 85, 4701–4705 (2000)PubMed B. Biondi, E.A. Palmieri, S. Fazio, C. Cosco, M. Nocera, L. Sacca, S. Filetti, G. Lombardi, F. Perticone, Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J. Clin. Endocrinol. Metab. 85, 4701–4705 (2000)PubMed
4.
go back to reference H. Vargas-Uricoechea, C.H. Sierra-Torres, Thyroid hormones and the heart. Horm Mol Biol Clin Investig 18, 15–26 (2014)PubMed H. Vargas-Uricoechea, C.H. Sierra-Torres, Thyroid hormones and the heart. Horm Mol Biol Clin Investig 18, 15–26 (2014)PubMed
5.
go back to reference J. Geng, W. Lu, T. Hu, S. Tao, H. Zhang, J. Chen, Y. Bu, S. Ma, B. Wang, Subclinical hyperthyroidism increases risk of coronary heart disease events in type 2 diabetes mellitus. Endocrine 49, 557–559 (2015)CrossRefPubMed J. Geng, W. Lu, T. Hu, S. Tao, H. Zhang, J. Chen, Y. Bu, S. Ma, B. Wang, Subclinical hyperthyroidism increases risk of coronary heart disease events in type 2 diabetes mellitus. Endocrine 49, 557–559 (2015)CrossRefPubMed
6.
go back to reference A.R. Cappola, L.P. Fried, A.M. Arnold, M.D. Danese, L.H. Kuller, G.L. Burke, R.P. Tracy, P.W. Ladenson, Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295, 1033–1041 (2006)CrossRefPubMedPubMedCentral A.R. Cappola, L.P. Fried, A.M. Arnold, M.D. Danese, L.H. Kuller, G.L. Burke, R.P. Tracy, P.W. Ladenson, Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295, 1033–1041 (2006)CrossRefPubMedPubMedCentral
7.
go back to reference G. Iervasi, S. Molinaro, P. Landi, M.C. Taddei, E. Galli, F. Mariani, A. L’Abbate, A. Pingitore, Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch. Intern. Med. 167, 1526–1532 (2007)CrossRefPubMed G. Iervasi, S. Molinaro, P. Landi, M.C. Taddei, E. Galli, F. Mariani, A. L’Abbate, A. Pingitore, Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch. Intern. Med. 167, 1526–1532 (2007)CrossRefPubMed
8.
go back to reference J.V. Parle, P. Maisonneuve, M.C. Sheppard, P. Boyle, J.A. Franklyn, Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358, 861–865 (2001)CrossRefPubMed J.V. Parle, P. Maisonneuve, M.C. Sheppard, P. Boyle, J.A. Franklyn, Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358, 861–865 (2001)CrossRefPubMed
9.
go back to reference J.P. Walsh, A.P. Bremner, M.K. Bulsara, P. O’Leary, P.J. Leedman, P. Feddema, V. Michelangeli, Subclinical thyroid dysfunction and blood pressure: a community-based study. Clin. Endocrinol. (Oxf) 65, 486–491 (2006)CrossRef J.P. Walsh, A.P. Bremner, M.K. Bulsara, P. O’Leary, P.J. Leedman, P. Feddema, V. Michelangeli, Subclinical thyroid dysfunction and blood pressure: a community-based study. Clin. Endocrinol. (Oxf) 65, 486–491 (2006)CrossRef
10.
go back to reference G. Ceresini, M. Marina, Approach to geriatric patients with subclinical thyroid disorders. Endocrine 47, 7–8 (2014)CrossRefPubMed G. Ceresini, M. Marina, Approach to geriatric patients with subclinical thyroid disorders. Endocrine 47, 7–8 (2014)CrossRefPubMed
11.
go back to reference G. Kaminski, K. Makowski, D. Michalkiewicz, J. Kowal, M. Ruchala, E. Szczepanek, G. Gielerak, The influence of subclinical hyperthyroidism on blood pressure, heart rate variability, and prevalence of arrhythmias. Thyroid 22, 454–460 (2012)CrossRefPubMed G. Kaminski, K. Makowski, D. Michalkiewicz, J. Kowal, M. Ruchala, E. Szczepanek, G. Gielerak, The influence of subclinical hyperthyroidism on blood pressure, heart rate variability, and prevalence of arrhythmias. Thyroid 22, 454–460 (2012)CrossRefPubMed
12.
go back to reference J.A. Sgarbi, F.G. Villaca, B. Garbeline, H.E. Villar, J.H. Romaldini, The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. J. Clin. Endocrinol. Metab. 88, 1672–1677 (2003)CrossRefPubMed J.A. Sgarbi, F.G. Villaca, B. Garbeline, H.E. Villar, J.H. Romaldini, The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. J. Clin. Endocrinol. Metab. 88, 1672–1677 (2003)CrossRefPubMed
13.
go back to reference G. Kaminski, D. Michalkiewicz, K. Makowski, Z. Podgajny, N. Szalus, M. Ruchala, E. Szczepanek, G. Gielerak, Prospective echocardiographic evaluation of patients with endogenous subclinical hyperthyroidism and after restoring euthyroidism. Clin. Endocrinol. (Oxf) 74, 501–507 (2011)CrossRef G. Kaminski, D. Michalkiewicz, K. Makowski, Z. Podgajny, N. Szalus, M. Ruchala, E. Szczepanek, G. Gielerak, Prospective echocardiographic evaluation of patients with endogenous subclinical hyperthyroidism and after restoring euthyroidism. Clin. Endocrinol. (Oxf) 74, 501–507 (2011)CrossRef
14.
go back to reference L. Hegedus, J. Faber, Calculation of the ideal dose of radioiodine for treatment of thyroid disease. Eur. J. Endocrinol. 132, 544–545 (1995)CrossRefPubMed L. Hegedus, J. Faber, Calculation of the ideal dose of radioiodine for treatment of thyroid disease. Eur. J. Endocrinol. 132, 544–545 (1995)CrossRefPubMed
15.
go back to reference R.A. Bruce, T.R. Hornsten, Exercise stress testing in evaluation of patients with ischemic heart disease. Prog. Cardiovasc. Dis. 11, 371–390 (1969)CrossRefPubMed R.A. Bruce, T.R. Hornsten, Exercise stress testing in evaluation of patients with ischemic heart disease. Prog. Cardiovasc. Dis. 11, 371–390 (1969)CrossRefPubMed
16.
go back to reference R.J. Gibbons, G.J. Balady, J.T. Bricker, B.R. Chaitman, G.F. Fletcher, V.F. Froelicher, D.B. Mark, B.D. McCallister, A.N. Mooss, M.G. O’Reilly, W.L. Winters Jr, E.M. Antman, J.S. Alpert, D.P. Faxon, V. Fuster, G. Gregoratos, L.F. Hiratzka, A.K. Jacobs, R.O. Russell, S.C. Smith Jr, ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 106, 1883–1892 (2002)CrossRefPubMed R.J. Gibbons, G.J. Balady, J.T. Bricker, B.R. Chaitman, G.F. Fletcher, V.F. Froelicher, D.B. Mark, B.D. McCallister, A.N. Mooss, M.G. O’Reilly, W.L. Winters Jr, E.M. Antman, J.S. Alpert, D.P. Faxon, V. Fuster, G. Gregoratos, L.F. Hiratzka, A.K. Jacobs, R.O. Russell, S.C. Smith Jr, ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 106, 1883–1892 (2002)CrossRefPubMed
17.
go back to reference P.O. Astrand, Quantification of exercise capability and evaluation of physical capacity in man. Prog. Cardiovasc. Dis. 19, 51–67 (1976)CrossRefPubMed P.O. Astrand, Quantification of exercise capability and evaluation of physical capacity in man. Prog. Cardiovasc. Dis. 19, 51–67 (1976)CrossRefPubMed
18.
go back to reference S.D. Fihn, J.M. Gardin, J. Abrams, K. Berra, J.C. Blankenship, A.P. Dallas, P.S. Douglas, J.M. Foody, T.C. Gerber, A.L. Hinderliter, S.B. King 3rd, P.D. Kligfield, H.M. Krumholz, R.Y. Kwong, M.J. Lim, J.A. Linderbaum, M.J. Mack, M.A. Munger, R.L. Prager, J.F. Sabik, L.J. Shaw, J.D. Sikkema, C.R. Smith Jr, S.C. Smith Jr, J.A. Spertus, S.V. Williams, 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 60, e44–e164 (2012)CrossRefPubMed S.D. Fihn, J.M. Gardin, J. Abrams, K. Berra, J.C. Blankenship, A.P. Dallas, P.S. Douglas, J.M. Foody, T.C. Gerber, A.L. Hinderliter, S.B. King 3rd, P.D. Kligfield, H.M. Krumholz, R.Y. Kwong, M.J. Lim, J.A. Linderbaum, M.J. Mack, M.A. Munger, R.L. Prager, J.F. Sabik, L.J. Shaw, J.D. Sikkema, C.R. Smith Jr, S.C. Smith Jr, J.A. Spertus, S.V. Williams, 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 60, e44–e164 (2012)CrossRefPubMed
19.
go back to reference R. Gianrossi, R. Detrano, D. Mulvihill, K. Lehmann, P. Dubach, A. Colombo, D. McArthur, V. Froelicher, Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 80, 87–98 (1989)CrossRefPubMed R. Gianrossi, R. Detrano, D. Mulvihill, K. Lehmann, P. Dubach, A. Colombo, D. McArthur, V. Froelicher, Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 80, 87–98 (1989)CrossRefPubMed
20.
go back to reference B. Biondi, S. Fazio, A. Cuocolo, D. Sabatini, E. Nicolai, G. Lombardi, M. Salvatore, L. Sacca, Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J. Clin. Endocrinol. Metab. 81, 4224–4228 (1996)PubMed B. Biondi, S. Fazio, A. Cuocolo, D. Sabatini, E. Nicolai, G. Lombardi, M. Salvatore, L. Sacca, Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J. Clin. Endocrinol. Metab. 81, 4224–4228 (1996)PubMed
21.
go back to reference G. Mercuro, M.G. Panzuto, A. Bina, M. Leo, R. Cabula, L. Petrini, F. Pigliaru, S. Mariotti, Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. J. Clin. Endocrinol. Metab. 85, 159–164 (2000)CrossRefPubMed G. Mercuro, M.G. Panzuto, A. Bina, M. Leo, R. Cabula, L. Petrini, F. Pigliaru, S. Mariotti, Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. J. Clin. Endocrinol. Metab. 85, 159–164 (2000)CrossRefPubMed
22.
go back to reference T.Y. Goraya, S.J. Jacobsen, P.A. Pellikka, T.D. Miller, A. Khan, S.A. Weston, B.J. Gersh, V.L. Roger, Prognostic value of treadmill exercise testing in elderly persons. Ann. Intern. Med. 132, 862–870 (2000)CrossRefPubMed T.Y. Goraya, S.J. Jacobsen, P.A. Pellikka, T.D. Miller, A. Khan, S.A. Weston, B.J. Gersh, V.L. Roger, Prognostic value of treadmill exercise testing in elderly persons. Ann. Intern. Med. 132, 862–870 (2000)CrossRefPubMed
23.
go back to reference Quantitative exercise testing for the cardiac patient: the value of monitoring gas exchange. Atlanta, Georgia, March 7–8, 1986. Proceedings. Circulation 76, VI1-58 (1987) Quantitative exercise testing for the cardiac patient: the value of monitoring gas exchange. Atlanta, Georgia, March 7–8, 1986. Proceedings. Circulation 76, VI1-58 (1987)
24.
go back to reference E.A. Amsterdam, D.T. Mason, Exercise testing and indirect assessment of myocardial oxygen consumption in evaluation of angina pectoris. Cardiology 62, 174–189 (1977)CrossRefPubMed E.A. Amsterdam, D.T. Mason, Exercise testing and indirect assessment of myocardial oxygen consumption in evaluation of angina pectoris. Cardiology 62, 174–189 (1977)CrossRefPubMed
25.
go back to reference R.R. Nelson, F.L. Gobel, C.R. Jorgensen, K. Wang, Y. Wang, H.L. Taylor, Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation 50, 1179–1189 (1974)CrossRefPubMed R.R. Nelson, F.L. Gobel, C.R. Jorgensen, K. Wang, Y. Wang, H.L. Taylor, Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation 50, 1179–1189 (1974)CrossRefPubMed
26.
go back to reference B. Biondi, E.A. Palmieri, G. Lombardi, S. Fazio, Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J. Clin. Endocrinol. Metab. 87, 968–974 (2002)CrossRefPubMed B. Biondi, E.A. Palmieri, G. Lombardi, S. Fazio, Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J. Clin. Endocrinol. Metab. 87, 968–974 (2002)CrossRefPubMed
27.
go back to reference J.P. Ioannidis, T.A. Trikalinos, P.G. Danias, Electrocardiogram-gated single-photon emission computed tomography versus cardiac magnetic resonance imaging for the assessment of left ventricular volumes and ejection fraction: a meta-analysis. J. Am. Coll. Cardiol. 39, 2059–2068 (2002)CrossRefPubMed J.P. Ioannidis, T.A. Trikalinos, P.G. Danias, Electrocardiogram-gated single-photon emission computed tomography versus cardiac magnetic resonance imaging for the assessment of left ventricular volumes and ejection fraction: a meta-analysis. J. Am. Coll. Cardiol. 39, 2059–2068 (2002)CrossRefPubMed
28.
go back to reference A.E. Iskandrian, G. Germano, W. VanDecker, J.D. Ogilby, N. Wolf, R. Mintz, D.S. Berman, Validation of left ventricular volume measurements by gated SPECT 99mTc-labeled sestamibi imaging. J. Nucl. Cardiol. 5, 574–578 (1998)CrossRefPubMed A.E. Iskandrian, G. Germano, W. VanDecker, J.D. Ogilby, N. Wolf, R. Mintz, D.S. Berman, Validation of left ventricular volume measurements by gated SPECT 99mTc-labeled sestamibi imaging. J. Nucl. Cardiol. 5, 574–578 (1998)CrossRefPubMed
29.
go back to reference F.M. Grund, C.B. Niewoehner, Hyperthyroxinemia in patients receiving thyroid replacement therapy. Arch. Intern. Med. 149, 921–924 (1989)CrossRefPubMed F.M. Grund, C.B. Niewoehner, Hyperthyroxinemia in patients receiving thyroid replacement therapy. Arch. Intern. Med. 149, 921–924 (1989)CrossRefPubMed
30.
go back to reference J. Faber, N. Wiinberg, S. Schifter, J. Mehlsen, Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur. J. Endocrinol. 145, 391–396 (2001)CrossRefPubMed J. Faber, N. Wiinberg, S. Schifter, J. Mehlsen, Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur. J. Endocrinol. 145, 391–396 (2001)CrossRefPubMed
Metadata
Title
Electrocardiographic and scintigraphic evaluation of patients with subclinical hyperthyroidism during workout
Authors
Grzegorz Kaminski
Mirosław Dziuk
Ewelina Szczepanek-Parulska
Ariadna Zybek-Kocik
Marek Ruchala
Publication date
01-08-2016
Publisher
Springer US
Published in
Endocrine / Issue 2/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-0877-x

Other articles of this Issue 2/2016

Endocrine 2/2016 Go to the issue